1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends

US Next-generation Sequencing Market

  • June 2014
  • 111 pages
  • Frost & Sullivan
Report ID: 2200859


Table of Contents

Marketplace Evolves in Preparation for Clinical Sequencing Windfall

The total market, as defined by this study, includes next-generation sequencing instruments and reagents in the United States. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research service offers a discussion of the key market drivers and restraints, revenue forecasts, and product types, as well as important trends affecting growth. This analysis also presents key companies to watch, major market dynamics, and strategic recommendations for competitors.


The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with next-generation sequencing instruments and reagents providers. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors in the next-generation sequencing market. Industry-specific information obtained include:
-Next-generation sequencing revenue breakdowns by technology segments and regions
-Company revenues, market share estimates, and projected growth rates of various competitors
-Top-level customer, regional, and technology market trend information
-Market drivers, restraints, and challenges Supplementary research was conducted utilizing secondary sources including scientific journals, online media, Frost & Sullivan databases and research services, and publicly available corporate filings. Forecasts are based on the data and analyses regarding industry challenges, market drivers and restraints, and market trends. If specific revenues or market sizes were unavailable, estimates were derived through the consultations with industry experts, augmented by secondary research. Growth trends specific to certain market participants are based on consultations, past growth rates, and technology reviews.

Key Findings

-The total US market for next-generation sequencing (NGS) instruments and reagents generated revenue of $ million in 2013, it is expected to reach $ million in 2018. The market is expected to grow at a CAGR of % from 2013 to 2018.
-The US market accounted for% of global combined NGS instruments and reagents revenue in 2013, while Europe accounted for % and APAC/ROW generated % of market revenue.
-The US NGS instruments market generated $ million in 2013, with a CAGR of % expected to result in a market size of $ million in 2018. The US NGS reagents market totaled $ million in 2013 and is expected to grow at a CAGR of % to $ million in 2018.
-The United States holds the largest NGS instruments installed base of all countries globally, which continues to drive a large reagent pull-through. Adoption of NGS instruments in clinically applied settings, such as reference laboratories, hospitals, and translational research laboratories, will account for more growth over the next 5 years than in traditional labs.
-The United States leads the world in the use of NGS in clinical diagnostics, with NGS-based laboratory developed tests (LDT) already in use, and an expanding pipeline of NGS-based in vitro diagnostic (IVD) tests in the US Food and Drug Administration (FDA) approval process. Between % and % of clinical sequencing is panel-based, while exome sequencing accounts for % to % and whole genomes roughly % to %.
-Market revenues are restrained by the declining instrument costs and reagent costs per genome, yet this trend is also spurring wider accessibility and larger throughput projects. Increasing competition over the next 3 years will further drive down pricing.
-Key vendors in the NGS instrumentation space are Illumina, Life Technologies, Pacific Biosciences and Roche (until the company exits the market in 2015). Emerging competitors expected to enter the NGS instruments market in 2014 or beyond include Oxford Nanopore, Qiagen (Intelligent BioSystems), GnuBIO (acquired by Bio-Rad in 2014), GenapSys, DNA Electronics, NabSys, Genia Technologies, and Noblegen Biosciences.
-Key vendors in the NGS reagents market include Illumina, Life Technologies, Roche, Agilent, Qiagen, and New England Biolabs. This competitor base includes a number of smaller participants, and is expected to expand as companies develop NGS products to take advantage of strong market growth.

The key factors affecting the US NGS market forecast follows:

Application Drivers
oThe price of sequencing falling near the $ genome mark, making large, whole-human genome sequencing projects and population studies feasible
oExpanding use for clinical diagnostics in the form of LDTs, IVD test panels, exome sequencing, and to a lesser extent, whole genome sequencing
oIncreasing use in pharmaceutical applications (i.e., clinical trials, patient stratification, and toxicogenomics)
Technology Trends
oFast pace of technological advancements drives new product launches, making older platforms obsolete and spurring upgrades
oLaunch of clinically focused instruments
oAdvancements in commercially available reagents that increase speed of sample preparation, lower sample volume requirement, and improve project accuracy
oImproved and simplified bioinformatics that enable better data analysis and clinical interpretation
oCreation of very large databases of sequencing and clinical data to improve the clinical utility of genomic information
Macroeconomic Trends
oUS sequestration measures in 2013 negatively affected the academic and government sectors overall, yet the percent of federal funding going to NGS-based projects continues to grow at a much faster pace than funding itself
oGiven the growth potential of NGS and clinical sequencing in particular, this industry is highly advantageous for venture capital funding
Regulatory Trends
oFurther definition of clinical standards and guidelines is needed
oFDA approval of NGS-based IVD tests needs more efficient process

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cell-based assays market projected to grow at a CAGR of 8.4% during the forecast period” The global cell-based assays market is expected to reach USD 19.92 billion by 2022, at a CAGR of 8.4% from ...

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

  • $ 5501
  • Industry report
  • June 2017
  • by BCC Research

• The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in ...

2017 Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 4500
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Norway diagnostic testing market, including volume and sales forecasts by test for the following market segments:      -  ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.